Sign in
Taking people in United StatesNo phase

Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) Intraocular Lens (IOL) in Adult Participants for Correction of Aphakia Following Cataract Extraction

Key facts

Who runs it
Kowa Research Institute, Inc.
Where
Beverly Hills, Gainesville, Grand Junction, Houston, Hurst, Lynchburg, Mt. Pleasant, and St Louis, United StatesSee the 9 sites
Trial code
Status
Recruiting
People taking part
340 people, planned
Started
30 Oct 2026
Expected to end
Sept 2028
Type of study
Interventional
Treatments tested
  • KI-362-US1 (YP2.2VM)
Record updated
13 November 2026

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Are able and willing to provide written informed consent, attend all scheduled visits, and comply with all trial procedures and follow-up
  • Have a study eye with visually significant cataract for which phacoemulsification cataract extraction and posterior chamber IOL implantation is indicated
  • Meet all other inclusion criteria outlined in the clinical study protocol

Who cannot take part

  • Within 30 days of the Screening Visit, use of systemic medications with significant ocular side effects or any medications that could confound the outcome or increase participant risk
  • Have serious systemic disease that could increase operative risk or conditions that can confound the surgical outcome
  • Meet any other exclusion criteria outlined in the clinical study protocol

Where in United States

  • Beverly Hills Institute of OphthalmologyBeverly Hills, United StatesContact: Director, Clinical OperationsTaking people
  • North Georgia Eye AssociatesGainesville, United StatesContact: Director, Clinical OperationsTaking people
  • Icon EyeCareGrand Junction, United StatesContact: Director, Clinical OperationsTaking people
  • Berkeley EyeHouston, United StatesContact: Director, Clinical OperationsTaking people
  • Houston Eye Associates, North LoopHouston, United StatesContact: Director, Clinical OperationsTaking people
  • Texas Eye ResearchHurst, United StatesContact: Director, Clinical OperationsTaking people
  • Piedmont Eye CenterLynchburg, United StatesContact: Director, Clinical OperationsTaking people
  • Carolina Eyecare PhysiciansMt. Pleasant, United StatesContact: Director, Clinical OperationsTaking people
  • Ophthalmology Consultants LtdSt Louis, United StatesContact: Director, Clinical OperationsTaking people

About the trial

What the trial wants to find out

This study is designed to evaluate how well an artificial lens, called an intraocular lens (IOL), performs in adults undergoing cataract surgery. During cataract surgery, the eye's natural lens is removed and replaced with an artificial lens to improve vision.

Read full original descriptionShow less

The main goal of the study is to evaluate participants' vision after the IOL is placed in the eye. Approximately one year after surgery, participants' vision will be assessed to determine how clearly they can see.

The results of this study will provide additional information about the performance of the IOL in adults undergoing cataract surgery.

The group in the trial

  • KI-362-US1Treatment being tested

    Participants receive an intraocular lens (IOL) implanted during cataract surgery to replace the natural lens of the eye. The IOL is delivered using a single-use, preloaded delivery device and positioned within the eye's natural lens capsule.

    Treatment: KI-362-US1 (YP2.2VM)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective, Multicenter, Open-label, Single-arm Clinical Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) IOL for Correction of Aphakia Following Cataract Extraction
Record updated
13 November 2026